Critical Quality Attributes for Adeno-Associated Virus Analysis
Key Learning Points:
Explore modern chromatographic techniques for AAV quantification and characterization.
Gain a comprehensive understanding of Critical Quality Attributes (CQAs) and their significance in drug development.
Learn to navigate common CQA challenges at different development stages for meeting industry standards.
Discover the importance of selecting tailored chemistries and method conditions to ensure robust, efficient, and precise analytical methods.
Who Should Attend:
- Any Analytical Development Scientists, QC Analysts / Managers, or R&D Scientists who are looking to learn more about the role of chromatography in ensuring AAV quality and safety in drug development.
Presenter: Shilin Lok Yee Cheung (Sr. Research Scientist, Phenomenex)
Dr. Cheung received her BS (2006) and Ph.D. (2012) in Bioanalytical Chemistry from the University of Toronto. She has developed, qualified, and validated innovative analytical methods in CE based microfluidics, automated low volume UV-vis spec., and UHPLC assays. Her methods have been applied to manufacturing process developments, formulation and stability and DS/DP characterization and specification testing. At the Phenomenex Innovation Campus she is focused on developing fit for purpose analytical methods to help advance developments in gene therapeutics.
